• Fate Therapeutics rises on Lupus drug data

  • Nov 19 2024
  • Length: 6 mins
  • Podcast

Fate Therapeutics rises on Lupus drug data

Listen for free

View show details

  • Summary

  • Fate Therapeutics (FATE) closes 12% higher after soaring 73% on drug data (update). (00:25) Super Micro (SMCI) announces appointment of independent auditor, filing of compliance plan with Nasdaq. (02:11) Blackstone (BX) is said to near acquisition of Jersey Mike's sandwich chain. (03:02)

    Episode transcripts seekingalpha.com/wsb.

    Show links:
    Biggest stock movers Tuesday: SMCI, INCY, and more
    Nippon Steel makes anti-import promise to win worker support for US Steel deal
    No time to chill: Netflix must fix livestreaming before Christmas NFL games or lose face
    DOJ to ask judge to push Google to sell Chrome browser - Bloomberg
    Apple said to offer $100M investment in Indonesia to reverse iPhone 16 ban

    Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Fate Therapeutics rises on Lupus drug data

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available